Dr. Candice Renee Lovelace, DO

Dr. Lovelace practices at Visalia Medical Clinic - Imaging - Adventist Health Physicians Network in Visalia, California.

Dr. Lovelace's NPI, 1215248307, was assigned on June 23, 2010. Dr. Lovelace graduated from Pcom in 2010. Dr. Lovelace holds Georgia license 4130.

Dr. Lovelace's primary practice is Visalia Medical Clinic - Imaging - Adventist Health Physicians Network, at 5400 W. Hillsdale, Visalia, CA 93291.

Dr. Lovelace's primary practice is Visalia Medical Clinic - Imaging - Adventist Health Physicians Network in Visalia, California. Dr. Lovelace is also affiliated with Kaweah Health Medical Center. The medical group on file is Adventist Health Physicians Network. Dmand AI also links Dr. Lovelace to 4 more home health agencies, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Lovelace's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lovelace practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Lovelace's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Lovelace is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Lovelace's licenses on file in 3 states: Georgia, California and South Carolina.

Dmand AI lists acid reflux, acne, acute gallbladder or bile duct inflammation, acute kidney failure, acute mini-stroke (TIA), acute sinusitis, acute skin infection and adjustment disease among the conditions Dr. Lovelace treats.

CMS data shows 3,646 Medicare services from Dr. Lovelace across 13 procedure codes in 2024, for 676 Medicare patients. Medicare paid $186,118 for them. Every service was in an office.

CMS counts 676 Medicare patients who saw Dr. Lovelace in 2024. The largest group is 75 to 84, with 281 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lovelace's median patient age at 67, with 70% women.

In 2024, Dr. Lovelace wrote 13,511 Medicare Part D claims for 975 patients. 89% of them were for generic drugs. CMS names the drug for 12,752 of them, across 176 drugs with 11 or more claims each, at $958,747 in total drug cost. In 2023, CMS named 11,397 claims across 174 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Lovelace for performance year 2024, reported through an alternative payment model (APM). Dr. Lovelace accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lovelace as offering telehealth.

CMS Open Payments shows 564 general payments to Dr. Lovelace from 45 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Novo Nordisk Inc paid the most, $1,672.

Dr. Lovelace graduated from Pcom in 2010.

Dr. Lovelace is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.